GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,766.50p
   
  • Change Today:
      36.50p
  • 52 Week High: 1,812.50p
  • 52 Week Low: 1,316.00p
  • Currency: UK Pounds
  • Shares Issued: 4,144.94m
  • Volume: 17,477,210
  • Market Cap: £73,220m
  • RiskGrade: 129

GSK plans return of HQ to central London in 2024

By Frank Prenesti

Date: Monday 12 Dec 2022

LONDON (ShareCast) - (Sharecast News) - GSK on Monday said it was moving its global headquarters back to central London in 2024.
The company will relocate from its current base in Brentford, West London - which it has occupied since 2002 - to new offices on New Oxford Street close to Tottenham Court Road.

It's new six storey building is under construction and due to be completed next year. Around 3000 people will work there on a hybrid basis including the GSK global leadership team headed by CEO Emma Walmsley.

GSK said the new HQ would allow it to be closer to London's so called Knowledge Quarter and key partners such as the Francis Crick Institute and King's College.

"The choice of central London offers easy access to GSK's global R&D hub in Stevenage, as well as closer proximity to the company's Artificial Intelligence and Machine Learning Hub in King's Cross," it added.

Reporting by Frank Prenesti for Sharecast.com

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,766.50p
Change Today 36.50p
% Change 2.11 %
52 Week High 1,812.50p
52 Week Low 1,316.00p
Volume 17,477,210
Shares Issued 4,144.94m
Market Cap £73,220m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
60.13% below the market average60.13% below the market average60.13% below the market average60.13% below the market average60.13% below the market average
17.65% above the sector average17.65% above the sector average17.65% above the sector average17.65% above the sector average17.65% above the sector average
Price Trend
51.02% above the market average51.02% above the market average51.02% above the market average51.02% above the market average51.02% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average
Income
7.92% above the market average7.92% above the market average7.92% above the market average7.92% above the market average7.92% above the market average
14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average
Growth
20.6% below the market average20.6% below the market average20.6% below the market average20.6% below the market average20.6% below the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average

What The Brokers Say

Strong Buy 8
Buy 5
Neutral 9
Sell 2
Strong Sell 0
Total 24
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 16-May-24 22-Feb-24
Paid 11-Jul-24 11-Apr-24
Amount 15.00p 16.00p

Trades for 31-May-2024

Time Volume / Share Price
16:51 4,960 @ 1,766.50p
16:51 4,960 @ 1,766.50p
16:47 5,664 @ 1,762.12p
16:42 14,195 @ 1,766.50p
16:42 30,128 @ 1,766.50p

GSK Key Personnel

CEO Emma Walmsley

Top of Page